4d08: Difference between revisions
From Proteopedia
Jump to navigationJump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
==PDE2a catalytic domain in complex with a brain penetrant inhibitor== | ==PDE2a catalytic domain in complex with a brain penetrant inhibitor== | ||
<StructureSection load='4d08' size='340' side='right' caption='[[4d08]], [[Resolution|resolution]] 1.90Å' scene=''> | <StructureSection load='4d08' size='340' side='right'caption='[[4d08]], [[Resolution|resolution]] 1.90Å' scene=''> | ||
== Structural highlights == | == Structural highlights == | ||
<table><tr><td colspan='2'>[[4d08]] is a 4 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4D08 OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4D08 FirstGlance]. <br> | <table><tr><td colspan='2'>[[4d08]] is a 4 chain structure with sequence from [http://en.wikipedia.org/wiki/Human Human]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4D08 OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4D08 FirstGlance]. <br> | ||
</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=MG:MAGNESIUM+ION'>MG</scene>, <scene name='pdbligand=Q2T:1-(5-BUTOXYPYRIDIN-3-YL)-4-METHYL-8-(MORPHOLIN-4-YLMETHYL)[1,2,4]TRIAZOLO[4,3-A]QUINOXALINE'>Q2T</scene>, <scene name='pdbligand=ZN:ZINC+ION'>ZN</scene></td></tr> | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=MG:MAGNESIUM+ION'>MG</scene>, <scene name='pdbligand=Q2T:1-(5-BUTOXYPYRIDIN-3-YL)-4-METHYL-8-(MORPHOLIN-4-YLMETHYL)[1,2,4]TRIAZOLO[4,3-A]QUINOXALINE'>Q2T</scene>, <scene name='pdbligand=ZN:ZINC+ION'>ZN</scene></td></tr> | ||
<tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[4d09|4d09]]</td></tr> | <tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[4d09|4d09]]</td></tr> | ||
| Line 28: | Line 28: | ||
</StructureSection> | </StructureSection> | ||
[[Category: 3',5'-cyclic-nucleotide phosphodiesterase]] | [[Category: 3',5'-cyclic-nucleotide phosphodiesterase]] | ||
[[Category: Human]] | |||
[[Category: Large Structures]] | |||
[[Category: Andres, J I]] | [[Category: Andres, J I]] | ||
[[Category: Buijnsters, P]] | [[Category: Buijnsters, P]] | ||
Revision as of 09:52, 20 March 2019
PDE2a catalytic domain in complex with a brain penetrant inhibitor
| ||||||||||||
Proteopedia Page Contributors and Editors (what is this?)
Categories:
- 3',5'-cyclic-nucleotide phosphodiesterase
- Human
- Large Structures
- Andres, J I
- Buijnsters, P
- DeAngelis, M
- Langlois, X
- Rombouts, F
- Sanderson, W
- Trabanco, A
- Tresadern, G
- VanHoof, G
- VanRoosbroeck, Y
- Animal
- Binding site
- Catalytic domain
- Cyclic nucleotide phosphodiesterase
- Disease model
- Drug evaluation
- Hydrolase
- Phosphodiesterase 2 inhibitor
- Phosphodiesterase inhibitor
- Preclinical
- Protein binding
- Structure-activity relationship
- Type 2
- Type 4